SCHEMBL8906225

SCHEMBL8906225

CCOC(=O)[C@H](C[C@H](c1ccc(C(C)(C)C)cc1)C(C)C)NC(=O)OC(C)(C)C

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.50
ALDH1A1 P00352 3/20 0.50
HTT P42858 2/20 0.46
CYP1A2 P05177 1/20 0.46
CYP2C9 P11712 1/20 0.46
CYP2C19 P33261 1/20 0.46
KDM4E B2RXH2 1/20 0.42
GAA P10253 1/20 0.42
PKM P14618 1/20 0.42
HPGD P15428 1/20 0.42
ALOX12 P18054 1/20 0.42
SMN1; SMN2 Q16637 3/20 0.40
CTSK P43235 3/20 0.40
ABCB1 P08183 1/20 0.39
NR1H4 Q96RI1 1/20 0.38
PPARG P37231 3/20 0.38
PPARA Q07869 3/20 0.38
SCN9A Q15858 1/20 0.38
CAPN1 P07384 1/20 0.37
LMNA P02545 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8906223 1.00 MAPT (0.50) MAPTALDH1A1HTTCYP1A2CYP2C9
SCHEMBL8905018 0.82 REN (0.44) MAPTALDH1A1HTTCYP1A2CYP2C9
SCHEMBL8905013 0.82 REN (0.44) MAPTALDH1A1HTTCYP1A2CYP2C9
SCHEMBL5312993 0.80 CTSS (0.50) MAPTALDH1A1HTTCYP1A2CYP2C9
SCHEMBL8905431 0.79 CYP1A2 (0.45) MAPTALDH1A1HTTCYP1A2CYP2C9
SCHEMBL8905435 0.79 CYP1A2 (0.45) MAPTALDH1A1HTTCYP1A2CYP2C9
SCHEMBL9596442 0.76 CYP1A2 (0.59) MAPTALDH1A1HTTCYP1A2CYP2C9
SCHEMBL15107084 0.76 CYP1A2 (0.59) MAPTALDH1A1HTTCYP1A2CYP2C9
SCHEMBL15374288 0.76 CYP1A2 (0.59) MAPTALDH1A1HTTCYP1A2CYP2C9
SCHEMBL12855166 0.75 CYP1A2 (0.58) MAPTALDH1A1HTTCYP1A2CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5659065-A CHEMICAL INTERMEDIATES FOR MEDICINAL ACTIVE AGENTS NOVARTIS CORPORATION (US) 1997-08-19 US claimed
EP-0678500-A1 Alpha-amino alkanoic acids and reduction products as intermediates in the preparation of renin inhibitors CIBA-GEIGY AG (CH) 1995-10-25 EP claimed
US-5659065-A CHEMICAL INTERMEDIATES FOR MEDICINAL ACTIVE AGENTS NOVARTIS CORPORATION (US) 1997-08-19 US disclosed
EP-0678500-A1 Alpha-amino alkanoic acids and reduction products as intermediates in the preparation of renin inhibitors CIBA-GEIGY AG (CH) 1995-10-25 EP disclosed